Literature DB >> 28355395

Obesity and kidney disease.

Geraldo Bezerra da Silva Junior1, Ana Carla Sobral Novaes Bentes1, Elizabeth De Francesco Daher2, Sheila Maria Alvim de Matos3.   

Abstract

Obesity has been pointed out as an important cause of kidney diseases. Due to its close association with diabetes and hypertension, excess weight and obesity are important risk factors for chronic kidney disease (CKD). Obesity influences CKD development, among other factors, because it predisposes to diabetic nephropathy, hypertensive nephrosclerosis and focal and segmental glomerulosclerosis. Excess weight and obesity are associated with hemodynamic, structural and histological renal changes, in addition to metabolic and biochemical alterations that lead to kidney disease. Adipose tissue is dynamic and it is involved in the production of "adipokines", such as leptin, adiponectin, tumor necrosis factor-α, monocyte chemoattractant protein-1, transforming growth factor-β and angiotensin-II. A series of events is triggered by obesity, including insulin resistance, glucose intolerance, dyslipidemia, atherosclerosis and hypertension. There is evidence that obesity itself can lead to kidney disease development. Further studies are required to better understand the association between obesity and kidney disease.

Entities:  

Mesh:

Year:  2017        PMID: 28355395     DOI: 10.5935/0101-2800.20170011

Source DB:  PubMed          Journal:  J Bras Nefrol        ISSN: 0101-2800


  19 in total

1.  Improvement of Renal Function After Bariatric Surgery: a Systematic Review and Meta-analysis.

Authors:  Hongyan Huang; Jun Lu; Xiaojiang Dai; Zhixin Li; Liyong Zhu; Shaihong Zhu; Liangping Wu
Journal:  Obes Surg       Date:  2021-08-06       Impact factor: 4.129

Review 2.  Renal Function Following Bariatric Surgery: a Literature Review of Potential Mechanisms.

Authors:  Zhixin Li; Yu Chen; Jinming Xiong; Qinglan Lyu; Bimei Jiang
Journal:  Obes Surg       Date:  2022-03-03       Impact factor: 3.479

3.  Obesity Management Education Needs Among General Internists: A Survey.

Authors:  Sanjeev Nanda; Jayanth Adusumalli; Ryan T Hurt; Karthik Ghosh; Karen M Fischer; Martha C Hagenbrock; Ravindra Ganesh; Basem M Ratrout; David Raslau; Darrell R Schroeder; Elizabeth C Wight; Carol L Kuhle; Lori A Thicke; Natalia Lazik; Ivana T Croghan
Journal:  J Prim Care Community Health       Date:  2021 Jan-Dec

4.  Rice bran modulates renal disease risk factors in animals submitted to high sugar-fat diet.

Authors:  Juliana Silva Siqueira; Fabiane Valentini Francisqueti-Ferron; Jéssica Leite Garcia; Carol Cristina Vágula de Almeida Silva; Mariane Róvero Costa; Erika Tiemi Nakandakare-Maia; Fernando Moreto; Ana Lúcia A Ferreira; Igor Otávio Minatel; Artur Junio Togneri Ferron; Camila Renata Corrêa
Journal:  J Bras Nefrol       Date:  2021 Apr-Jun

5.  Increased macrophage activation marker soluble CD163 is associated with graft dysfunction and metabolic derangements in renal transplant recipients.

Authors:  Hayam El Aggan; Sabah Mahmoud; Heba El Shair; Hazem Elabd
Journal:  Biomed J       Date:  2020-10-01       Impact factor: 7.892

6.  Cost of chronic kidney disease attributable to diabetes from the perspective of the Brazilian Unified Health System.

Authors:  Gabriela Maria Reis Goncalves; Everton Nunes da Silva
Journal:  PLoS One       Date:  2018-10-01       Impact factor: 3.240

7.  Prevalence of Early Chronic Kidney Disease and Main Associated Factors in Spanish Population: Populational Study.

Authors:  Carmen Expósito; Guillem Pera; Lluís Rodríguez; Ingrid Arteaga; Alba Martínez; Alba Alumà; María Doladé; Pere Torán; Llorenç Caballeria
Journal:  J Clin Med       Date:  2019-09-04       Impact factor: 4.241

8.  Metabolic healthy obesity is associated with higher incidence of mild decrease estimate glomerular rate in rural northeast Chinese.

Authors:  Shasha Yu; Xiaofan Guo; Guang Xiao Li; Hongmei Yang; Liqiang Zheng; Yingxian Sun
Journal:  BMC Nephrol       Date:  2020-11-24       Impact factor: 2.388

Review 9.  Impact of adipose tissue in chronic kidney disease development (Review).

Authors:  Daniela Miricescu; Daniela Gabriela Balan; Adrian Tulin; Ovidiu Stiru; Ileana Adela Vacaroiu; Doina Andrada Mihai; Cristian Constantin Popa; Mihaly Enyedi; Andrei Sorin Nedelea; Adriana Elena Nica; Constantin Stefani
Journal:  Exp Ther Med       Date:  2021-03-23       Impact factor: 2.447

Review 10.  The Causes and Potential Injurious Effects of Elevated Serum Leptin Levels in Chronic Kidney Disease Patients.

Authors:  Justyna Korczynska; Aleksandra Czumaj; Michal Chmielewski; Julian Swierczynski; Tomasz Sledzinski
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.